my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Roche and CuraGen announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing. Under the terms of the agreement, Roche will pay 454 Life Sciences' shareho more
TopoTarget A/S and CuraGen Corporation announced the initiation of patient dosing in a Phase II open-label, multi-center clinical trial evaluating the efficacy and safety of intravenous belinostat (PXD101), a small molecule histone deacetylase (HDAC) inhibitor, in combination with Velcade® (bortezom more
TopoTarget A/S and CuraGen Corporation announced the initiation of patient dosing in a Phase II clinical trial evaluating the antitumor activity of intravenous PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of ovarian cancer. This trial is being sponsored by the Nat more
What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. We provide research, data and opinions to benefit your work now. What revenues will cancer treatment markets generate from 2011 to 2021 more
How will the genomic sequencing market develop this decade? Our new report shows you that industry and market's revenue potential from 2011 to 2021, discussing its prospects. This report covers technology to support genomics, with an emphasis on pharma R&D. We aim to save you time and aid your deci more
Overview Business Strategy Management Team Board Of Directors Scientific Advisory Board Clinical Advisory Board From Heparin to Glycodrugs Endotis Pharma Drug Discovery Engine Targeted Diseases R&D Programs Board Of Directors Management Board Charles Woler, MD Chairman of the Board and Chief Executi more
Search: Home About Us Models The Biomodels Advantage Contact News Login Professional Profiles Management Professional Staff Advisors Management Edward G. Fey, Ph.D. Managing Partner Dr. Fey is one of the founders of Biomodels, and provides expertise in the areas of intellectual property and study more
For Physicians | For Investors | For Pharmacists | Contact Us 2010 Press Releases June 24, 2010 May 13, 2010 May 11, 2010 Conference Call May 11, 2010 May 7, 2010 May 6, 2010 May 4, 2010 March 8, 2010 March 5, 2010 March 3, 2010 Conference Call March 3, 2010 February 26, 2010 February 2, more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
